← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab with etoposide and Carboplatin/Cisplatin)

Large Cell Neuroendocrine Carcinoma of the Lung · Large Cell Neuroendocrine Carcinoma of t

#LargeCellNeuroendocrineCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab+AZD2811 to SCLC patients)

SCLC, Recurrent · SCLC, Recurrent

#SCLCRecurrent#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab+doxorubicin cobination)

Sarcoma · Sarcoma

#Sarcoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 3

durvalumab (Imfinzi, Durvalumab, Gemcitabine, Cisplatin)

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, Tremelimumab and ,FOLFOX)

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, etoposide, and cisplatin/carboplatin followed by durvalumab and olaparib)

Lung Cancer; Small Cell Lung Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, pazopanib)

Sarcoma · Sarcoma

#Sarcoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting)

HCC - Hepatocellular Carcinoma · HCC - Hepatocellular Carcinoma

#HCC-HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E1 - mFOLFOX and durvalumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E2 - mFOLFOX6, durvalumab and oleclumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E3 - mFOLFOX6, durvalumab and monalizumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEssen BiotechPhase 2

pembrolizumab (Keytruda, EBNK-001 + IL-15 + Pembrolizumab)

Cancer; Sarcoma · Cancer

#Cancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAmgenPhase 3

nivolumab (Opdivo, EU-authorized Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

Herceptin® (EU-sourced Trastuzumab, EU-sourced Trastuzumab (Herceptin®))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

EZN-2208, Cetuximab and Irinotecan (EZN-2208, Cetuximab and Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Early treatment of relapse with carfilzomib, dexamethasone, daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZeneca Rare DiseaseApproved

Eculizumab+IVMP (Eculizumab+IVMP)

Neuromyelitis Optica Spectrum Disorder Attack · Neuromyelitis Optica Spectrum Disorder A

#NeuromyelitisOpticaSpectrumDisor#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Illinois at Chica…Phase 3

Elra (Elranatamab, Elranatamab (Elra))

Plasmablastic Lymphoma; Hiv · Plasmablastic Lymphoma

#PlasmablasticLymphoma#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystalePfizerPhase 2

Elranatamab + Nirogacestat (Elranatamab + Nirogacestat)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED

44 / 92 페이지

← 이전다음 →